Johnson & Johnson
JNJHealthcare|Drug Manufacturers - General|USA
$240.97
-2.07 (-0.85%)
DCF (FCF)
$109.52
Earnings Power
$76.17
About
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Stock Price
+50.8%(1Y)
Pipeline Summary
500 total trials74
Phase 1
61
Phase 2
80
Phase 3
31
Phase 4
Completed: 412Terminated: 29Withdrawn: 8Unknown: 17Recruiting: 16Active: 11NOT_YET_RECRUITING: 5SUSPENDED: 1ENROLLING_BY_INVITATION: 1
Active Trials (27)
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
NCT07225101Wound Closure
Phase 4Recruiting
Enrollment: 160 participants
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
NCT05651945Stroke
N/ARecruiting
Enrollment: 150 participants
Canadian Orthopaedic Foot and Ankle Society Surgical Treatment of Ankle Arthritis Outcome Study
NCT00552136Ankle Arthritis
N/AActive
Enrollment: 250 participants
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200Lymphoma, B-Cell
Phase 4Active
Enrollment: 297 participants
Evaluation of Effect of Scatter on Visual Performance
NCT07443215Visual Acuity
N/ARecruiting
Enrollment: 36 participants
BioScore
6.4/10
Watchlist
Ownership
Recent Insider Trades
Decker Robert JSELL
2026-02-274,075 shares @ $247.87
Schmid TimothySELL
2026-02-201,322 shares @ $245.66
Schmid TimothySELL
2026-02-1822,623 shares @ $244.33
REED JOHN CSELL
2026-02-1753,931 shares @ $243
Swanson James D.SELL
2026-02-1762,080 shares @ $243.39
Recent News
2026-04-07 13:00:06
2026-04-07 12:56:36
2026-03-30 21:49:39
2026-03-30 21:06:17
2026-03-30 21:02:44
Data last updated: Apr 7, 2026, 01:23 PM